Articles tagged as

Drug Manufacturers - Major

  1. The Biggest Risks of Investing in Pfizer Stock

  2. Johnson & Johnson Stock: A Dividend Analysis

  3. This Resilient Stock Should be on Your Watch List

  4. The 5 Best Dividend Stocks in the Healthcare Sector

  5. Top 5 Health Mutual Funds

  6. Should You Avoid Biotech Stocks Right Now?

  7. 4 Trends Driving M&A in the Healthcare Industry in 2015

  8. Are Drug Price Controls Viable in the U.S.?

  9. ETF Analysis: Direxion Daily Healthcare Bull 3X

  10. Healthcare M&A and Prescription Drug Prices

  11. Valeant Pharmaceuticals acquires Sprout Pharmaceuticals

  12. ETF Analysis: PowerShares Dynamic Pharmaceuticals

  13. Is the Ebola Epidemic Officially Over?

  14. Sarepta Therapeutics Made Investors Millionaires in 2 Years

  15. Celgene Vs. Gilead: Vetting for the Best Biopharma

  16. Make Room for Exelixis in Your Portfolio

  17. Drugmaker Extraordinaire: How Eli Lilly Grows

  18. ETF Analysis: Market Vectors Pharmaceutical

  19. Are Bears About to Burst the Biotech Bubble?

  20. Pfizer CEO: The Story Behind Ian Read

  21. 10 Developments By Gilead Sciences That Could Boost Profits

  22. Are These 2015's 10 Best Generic Pharma Stocks?

  23. How to Profit from the Generic Drug Trend

  24. From Startup To Blue Chip: The Success Story Of Gilead Sciences Inc.

  25. Top 10 Pfizer Venture Investments

  26. Is It Too Late To Invest In Gilead Sciences?

  27. How Does Biogen Make its Money?

  28. Small-Cap Biotech Stocks to Watch

  29. Are These the Top 3 Value Stocks of 2015?

  30. 3 Top Pharma Stocks that Pay Regular Dividends

  31. How to Analyze Pharma Stock Fundamentals

  32. How Bristol-Myers Squibb Makes the World Healthier

  33. How is a Spinoff Worth $100 Billion? See AbbVie

  34. Why These Could Be 2015's 10 Best Biotech Stocks

  35. Why These Could Be 2015's 10-Best Pharma Stocks

  36. Why These ETFs are the Best Way to Trade Pfizer

  37. Could Amgen's Next Drug Be Worth $100 Billion?

  38. Has The Time Come To Sell Vertex Pharmaceuticals?

  39. Why Celgene Won't Pay A Dividend Anytime Soon

  40. Could This Drug Make Isis Pharmaceuticals Soar?

  41. What Biotech Stock To Buy When The Market Tumbles?

  42. Did Orexigen Make A Big Mistake?

  43. Are These Biogen Idec's Next Blockbusters?

  44. Why Does Wall Street Hate MannKind?

  45. Is Exelixis Under-the-Radar Growth?

  46. Is Arena Pharmaceuticals In Trouble?

  47. What’s The Drug That Will Finally Fight Obesity?

  48. Should You Invest In Oraganovo Holdings?

  49. What Is Amgen’s New Target?

  50. Will MannKind Finally Reach A Solid Ground?

  51. Should We Be Concerned For Sarepta’s Share Prices?

  52. What Are The Real Economic Costs Of Obesity?

  53. Gilead Sciences: The New Market-Share Leader

  54. Sun Pharma And Ranbaxy: An Ideal Pharma Marriage?

  55. Dilip Shanghvi's Net Worth: How Did He Get So Rich?

  56. How Amgen Makes Billions On Just A Few Drugs

  57. How Merck Found Its Way Into Millions Of Medicine Cabinets

  58. How Gilead Sciences Became A Big Name In Biotech

  59. Want To Make Money In Marijuana? Read This First

  60. What Are The Best Bets In Biotech?

  61. How Some Brands Come Back from Near Death

  62. It's No Accident That Drugs Are Expensive

  63. Will Immunotherapy Disrupt The Oncology Market?

  64. 8 Stages Of New Drug Development

  65. Big Pharma Faces 'Pay For Delay' Lawsuits

Trading Center